BLTE logo
NASDAQ · BLTEBiotechnologyUpdated Nov 4, 2026

Belite Bio, Inc ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Belite Bio, Inc (BLTE) is -15.65%

According to Belite Bio, Inc’s latest financial reports and current stock price. The company's current ROE is -15.65%. This represents a change of 243.04% compared to the average of -4.56% of the last 4 quarters.

Belite Bio, Inc (BLTE) Historical ROE (quarterly & annually)

How has BLTE ROE performed in the past?

The mean historical ROE of Belite Bio, Inc over the last ten years is 7.58%. The current -15.65% ROE has changed -306.41% with respect to the historical average. Over the past ten years (40 quarters), BLTE's ROE was at its highest in in the March 2020 quarter at 60.03%. The ROE was at its lowest in in the September 2022 quarter at -5790.22%.

Quarterly (TTM)
Annual

Average

7.58%

Median

-17.43%

Minimum

-34.98%

Maximum

81.75%

Belite Bio, Inc (BLTE) ROE by Quarter and Year

Discovering the peaks and valleys of Belite Bio, Inc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 14.77%

Maximum Annual ROE = 81.75%

Minimum Annual Increase = -147.59%

Minimum Annual ROE = -34.98%

Quarterly (TTM)
Annual
YearROEChange
2025-10.07%-59.36%
2024-24.79%-29.14%
2023-34.98%14.77%
2022-30.48%-147.59%
202164.04%-21.66%

Belite Bio, Inc (BLTE) Average ROE

How has BLTE ROE performed in the past?

The current ROE of Belite Bio, Inc (BLTE) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-23.28%

5-year avg

-7.25%

10-year avg

7.58%

Belite Bio, Inc (BLTE) ROE vs. Peers

How is BLTE’s ROE compared to its peers?

Belite Bio, Inc’s ROE is greater than Kodiak Sciences Inc. (-273.23%), less than Opus Genetics, Inc. (1.15%), less than Ocugen, Inc. (643.95%), greater than Kalaris Therapeutics Inc (-71.71%), greater than EyePoint Pharmaceuticals, Inc. (-135.81%),

Build a custom stock screener for Belite Bio, Inc (BLTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Belite Bio, Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Belite Bio, Inc (BLTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Belite Bio, Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Belite Bio, Inc's ROE?

How is the ROE calculated for Belite Bio, Inc (BLTE)?

What is the highest ROE for Belite Bio, Inc (BLTE)?

What is the 3-year average ROE for Belite Bio, Inc (BLTE)?

What is the 5-year average ROE for Belite Bio, Inc (BLTE)?

How does the current ROE for Belite Bio, Inc (BLTE) compare to its historical average?